
Domainex and Pharmacelera Join Forces to Accelerate Discovery of Molecules Targeting Transmembrane Proteins
Cambridge, UK & Barcelona, Spain — August 27th, 2025 — Domainex, a leading integrated drug discovery services company, and Pharmacelera, a pioneer